Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.61% | 5.10% | -1.34% | -10.99% | -5.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.61% | 5.10% | -1.34% | -10.99% | -5.33% |
| Cost of Revenue | 1.61% | -45.56% | -82.94% | -79.13% | -81.95% |
| Gross Profit | 10.44% | 39.88% | 1,497.54% | 703.78% | 988.40% |
| SG&A Expenses | -8.87% | -8.66% | -8.78% | -8.10% | -3.24% |
| Depreciation & Amortization | -0.23% | 0.24% | 0.29% | 0.29% | 0.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.41% | -10.11% | -8.11% | -6.59% | -2.90% |
| Operating Income | 29.50% | 22.95% | 14.35% | 2.19% | 0.59% |
| Income Before Tax | 34.05% | 29.16% | 0.34% | -11.82% | -10.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.05% | 29.16% | 0.34% | -11.82% | -10.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.38% | 90.74% | 50.72% | 28.40% | -33.05% |
| Net Income | 34.05% | 29.19% | 0.36% | -11.81% | -10.20% |
| EBIT | 29.50% | 22.95% | 14.35% | 2.19% | 0.59% |
| EBITDA | 31.40% | 24.13% | 15.07% | 2.25% | 1.08% |
| EPS Basic | 35.36% | 30.45% | 1.85% | -10.21% | -8.70% |
| Normalized Basic EPS | 31.19% | 24.87% | 16.66% | 5.10% | 2.66% |
| EPS Diluted | 35.36% | 30.45% | 1.85% | -10.21% | -8.35% |
| Normalized Diluted EPS | 31.19% | 24.87% | 16.66% | 5.10% | 2.66% |
| Average Basic Shares Outstanding | 2.07% | 1.88% | 1.73% | 1.55% | 1.39% |
| Average Diluted Shares Outstanding | 2.07% | 1.88% | 1.73% | 1.55% | 1.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |